Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:06 pm Sale | 13G | PRAXIS PRECISION MEDICINES INC PRAX | PFM Health Sciences LP | 656,548 0.5% | -2,120,919 (-76.36%) | View |
| 2024-02-14 4:06 pm Sale | 13G | BLUEBIRD BIO INC BLUE | PFM Health Sciences LP | 2,042,651 1.9% | -3,979,192 (-66.08%) | View |
| 2024-02-14 4:06 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | PFM Health Sciences LP | 6,480,764 7.3% | 2,020,981 (+45.32%) | View |
| 2024-02-14 4:06 pm Sale | 13G | ESSA PHARMA INC EPIX | PFM Health Sciences LP | 3,262,500 7.4% | -581,832 (-15.13%) | View |
| 2024-02-14 4:06 pm Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | PFM Health Sciences LP | 3,468,177 9.6% | 1,646,357 (+90.37%) | View |
| 2023-04-21 4:08 pm Purchase | 13G | BLUEBIRD BIO INC BLUE | PFM Health Sciences LP | 6,021,843 5.7% | 6,021,843 (New Position) | View |
| 2023-02-14 4:06 pm Sale | 13G | IO BIOTECH INC IOBT | PFM Health Sciences LP | 507,640 1.8% | -1,002,496 (-66.38%) | View |
| 2023-02-14 4:06 pm Sale | 13G | GENERATION BIO CO GBIO | PFM Health Sciences LP | 2,903,192 4.9% | -110,520 (-3.67%) | View |
| 2023-02-14 4:06 pm Sale | 13G | JOUNCE THERAPEUTICS INC. JNCE | PFM Health Sciences LP | 345,926 0.7% | -3,626,942 (-91.29%) | View |
| 2023-02-14 4:06 pm Sale | 13G | OUTSET MED INC OM | PFM Health Sciences LP | 0 0% | -2,940,255 (Position Closed) | View |
| 2023-02-14 4:06 pm Sale | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | PFM Health Sciences LP | 29,061,060 3% | -25,597,620 (-46.83%) | View |
| 2023-02-14 4:06 pm Purchase | 13G | PRAXIS PRECISION MEDICINES INC PRAX | PFM Health Sciences LP | 2,777,467 5.9% | 297,931 (+12.02%) | View |
| 2023-02-14 4:06 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | PFM Health Sciences LP | 2,703,287 3.7% | -1,229,946 (-31.27%) | View |
| 2023-02-14 4:06 pm Sale | 13G | UNIQURE N V QURE | PFM Health Sciences LP | 2,302,314 4.9% | -90,997 (-3.80%) | View |
| 2023-02-14 4:06 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | PFM Health Sciences LP | 4,459,783 7.3% | 367,474 (+8.98%) | View |
| 2023-02-14 4:06 pm Sale | 13G | ERASCA INC ERAS | PFM Health Sciences LP | 4,797,460 3.2% | -2,953,028 (-38.10%) | View |
| 2023-02-14 4:06 pm Sale | 13G | AXSOME THERAPEUTICS INC AXSM | PFM Health Sciences LP | 1,391,831 3.2% | -767,902 (-35.56%) | View |
| 2023-02-14 4:06 pm Unchanged | 13G | ESSA PHARMA INC EPIX | PFM Health Sciences LP | 3,844,332 8.7% | 0 (Unchanged) | View |
| 2023-01-17 4:01 pm Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | PFM Health Sciences LP | 1,821,820 5.3% | 528,527 (+40.87%) | View |
| 2023-01-17 1:20 pm Sale | 13G | WEREWOLF THERAPEUTICS INC HOWL | PFM Health Sciences LP | 1,293,293 4.2% | -223,733 (-14.75%) | View |